Cover Image
市場調查報告書

醫藥品原料藥 (API) 的全球市場 2015∼2023年:產業分析,規模,佔有率,成長,趨勢及預測

Active Pharmaceutical Ingredient Market: (Manufacturing Process, Drug Type, Therapeutic Area) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 328538
出版日期 內容資訊 英文 115 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品原料藥 (API) 的全球市場 2015∼2023年:產業分析,規模,佔有率,成長,趨勢及預測 Active Pharmaceutical Ingredient Market: (Manufacturing Process, Drug Type, Therapeutic Area) Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2016年03月23日 內容資訊: 英文 115 Pages
簡介

本報告提供全球醫藥品原料藥 (API) 市場相關調查,市場收益的實際成果、預測,市場促進要素、阻礙要素分析,各API製造的類型、API類型、醫藥品類型、治療領域、地區的分析與預測,競爭情形,及主要企業簡介等彙整,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 簡介
  • 市場動態
  • 活動的影響分析
  • 價值鏈分析
  • 波特的五力分析
  • 市場魅力度分析
  • 競爭情形

第4章 全球醫藥品原料藥市場:各製造工程

  • 簡介
  • 專屬式或公司內部API製造市場
  • API受託製造市場

第5章 全球醫藥品原料藥市場:API各類型

  • 簡介
  • 化學合成API市場
  • 生技藥品API市場

第6章 全球醫藥品原料藥市場:各醫藥品類型

  • 簡介
  • 品牌處方藥
  • 非專利處方藥
  • 成藥 (OTC藥)

第7章 全球醫藥品原料藥市場:各治療領域

  • 簡介
  • 循環系統疾病藥
  • 代謝障礙藥
  • 神經疾病藥
  • 抗癌劑
  • 肌肉骨骼系統藥
  • 非類固醇抗發炎藥物(NSAIDs)
  • 其他的治療藥物

第8章 全球醫藥品原料藥市場:各地區

  • 簡介
  • 北美
  • 亞太地區
  • 歐洲
  • 其他 (ROW)

第9章 建議

  • 目標地區的收購,強化製造能力
  • 特定的API分子中達成成本領先

第10章 企業簡介

  • Allergan plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Dr. Reddy's Laboratories
  • Lonza Group
  • Mylan N.V.
  • Pfizer, Inc.
  • Sandoz (Novartis AG)
  • Teva Pharmaceutical Industries Ltd.
  • WuXi AppTec

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. APIs of good quality are essential for the manufacture of effective and safe medicines. However, not all pharmaceutical companies possess in-house API manufacturing capabilities. Furthermore, a single company cannot produce all the APIs required for their formulation offerings.

The global active pharmaceutical ingredients market has been broadly segmented on the basis of manufacturing process, type of active pharmaceutical ingredient, types of drugs, therapeutic areas and geography. This report analyzes the current scenario as well as future market potential for active pharmaceutical ingredients market globally. This report comprises an elaborate executive summary, demonstrating a snapshot on market dynamics of various segments and sub-segments in a precise manner. Moreover, executive summary also comprises a waterfall chart, which reflects the market size of various segments in descending order.

The report provides detailed qualitative analysis of the market dynamics that affect the growth of the global active pharmaceutical ingredients market. Factors responsible for driving and restraining the growth of the global active pharmaceutical ingredients market and future opportunities has been provided in the market overview section. This section of the report also provides comprehensive market comparative analysis and market attractiveness analysis for the global active pharmaceutical ingredients market by geography for the base year, Porter's Five Forces analysis, and market share analysis by key players (%) for the base year, operating in the active pharmaceutical ingredients market. The report also encompasses detailed event impact analysis and value chain analysis for the global active pharmaceutical ingredients market.

The global active pharmaceutical ingredient market is categorized in to captive manufacturing and contract manufacturing. Types of active pharmaceutical ingredients described in the global active pharmaceutical ingredient market include synthetic chemical API and biological API. Branded prescription drugs, generic prescription drugs, and over-the-counter drugs are various types of drugs covered in the global active pharmaceutical ingredients market. The global active pharmaceutical ingredients market encompasses various therapeutic areas such as cardiovascular disorders, oncology, metabolic disorders, neurological disorders, musculoskeletal disorders, NSAIDs and other therapeutic uses (such as infectious diseases). The market for these types has been extensively analyzed based on consistency, effectiveness, and sales revenue of the various products developed by the manufacturers.

Geographies discussed and analyzed in the global active pharmaceutical ingredients market include North America, Europe, Asia Pacific, and Rest of the World. In addition the report also comprises the precise and detailed country wise analysis for the global active pharmaceutical ingredients market such as North America (U.S. and Canada), Asia Pacific (China, Japan, India and Rest of Asia Pacific), and Europe (Germany, U.K. and Rest of Europe). The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report on the active pharmaceutical ingredients market also provides compound annual growth rate (CAGR %) for each of the market segments mentioned above for the forecast period from 2015 to 2023, considering 2014 as the base year.

A list of recommendations have been provided for new entrants to help establish a strong presence and for existing market players to take strategic decisions and to increase their market shares in the global active pharmaceutical ingredient market. The report concludes with the profiles of major players in the active pharmaceutical ingredients market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Allergan plc, BASF SE, Boehringer Ingelheim Group, Cambrex Corporation, Dr. Reddy's Laboratories Ltd., Lonza Group, Mylan, Inc., Sandoz (Novartis AG), Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and WuXi Apptec.

The global active pharmaceutical ingredients market is segmented as follows:

Global Active Pharmaceutical Ingredients Market, by Manufacturing Process, 2013-2023 (US$ Mn)

  • Captive Manufacturing
  • Contract Manufacturing

Global Active Pharmaceutical Ingredients Market, by API Type, 2013 - 2023 (US$ Mn)

  • Synthetic Chemical API
  • Biological API

Global Active Pharmaceutical Ingredients Market, by Drug Type, 2013 - 2023 (US$ Mn)

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs

Global Active Pharmaceutical Ingredients Market, by Therapeutic Area, 2013 - 2023 (US$ Mn)

  • Cardiovascular Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal Disorders
  • NSAIDs
  • Other Therapeutics Uses

Global Active Pharmaceutical Ingredients Market, by Geography, 2013 - 2023 (US$ Mn)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

Chapter 2 Executive Summary

  • 2.1 Introduction
  • 2.2 Global Active Pharmaceutical Ingredients Market: Market Snapshot
  • 2.3 Comparative Analysis: Global Active Pharmaceutical Ingredients Market, by Geography (2015 & 2023)
  • 2.4 Waterfall Diagram: Global API Market Revenue, by Therapeutic Area, 2015 (US$ Mn)

Chapter 3 Market Overview

  • 3.1 Introduction
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
      • 3.2.1.1 Increase in healthcare expenditure to drive market growth
      • 3.2.1.2 Rapidly aging of global population expected to aid growth of the API market
      • 3.2.1.3 Increase in Abbreviated New Drug Applications (ANDA) in the recent past to boost the demand for APIs
    • 3.2.2 Restraint
      • 3.2.2.1 Adverse regulatory policies to be an important restraining factor
    • 3.2.3 Opportunity
      • 3.2.3.1 Patent Expiry of Major Biological Drugs in the U.S. and EU
      • 3.2.3.2 Growth of the healthcare market in Asia-Pacific and rest of the world (RoW) segments
  • 3.3 Event Impact Analysis
  • 3.4 Value Chain Analysis
  • 3.5 Porter's Five Forces Analysis
  • 3.6 Market Attractiveness Analysis: Global Active Pharmaceutical Ingredients Market, by Geography, 2015
  • 3.7 Competitive Landscape: Global Active Pharmaceutical Ingredients Market, by Key Players, 2015 (USD Million)

Chapter 4 By Manufacturing Process

  • 4.1 Introduction
  • 4.2 Captive Manufacturing Market Revenue, 2013-2023 (US$ Mn)
  • 4.3 Contract Manufacturing Market Revenue, 2013-2023 (US$ Mn)

Chapter 5 By API Type

  • 5.1 Introduction
  • 5.2 Synthetic Chemical Market Revenue, 2013-2023 (US$ Mn)
  • 5.3 API Biological API Market Revenue, 2013-2023 (US$ Mn)

Chapter 6 By Drug Type

  • 6.1 Introduction
  • 6.2 API Market Revenue for Branded Prescription Drugs, 2013-2023 (US$ Mn)
  • 6.3 API Market Revenue for Generic Prescription Drugs, 2013-2023 (US$ Mn)
  • 6.4 API Market Revenue for OTC Prescription Drugs, 2013-2023 (US$ Mn)

Chapter 7 By Therapeutic Area

  • 7.1 Introduction
  • 7.2 API Market Revenue for Cardiovascular Disorders Drug, 2013-2023 (US$ Mn)
  • 7.3 API Market for Drugs for Metabolic Disorders, 2013-2023 (US$ Mn)
  • 7.4 API Market for Drugs for Neurological Disorders, 2013-2023 (US$ Mn)
  • 7.5 API Market for Drugs for Oncology, 2013-2023 (US$ Mn)
  • 7.6 API Market for Drugs for Musculoskeletal Disorders, 2013-2023 (US$ Mn)
  • 7.7 API Market for NSAIDs, 2013-2023 (US$ Mn)
  • 7.8 API Market for Drugs for Other Therapeutics Uses, 2013-2023 (US$ Mn)

Chapter 8 By Region

  • 8.1 Introduction
  • 8.2 North America API Market Revenue, by Country, 2013-2023 (US$ Mn)
    • 8.2.1 U.S. API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.2.2 Canada API Market Revenue, 2013-2023, (US$ Mn)
  • 8.3 Asia-Pacific Market Revenue, by Country, 2013-2023 (US$ Mn)
    • 8.3.1 China API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.3.2 Japan API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.3.3 India API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.3.4 Rest of Asia-Pacific API Market Revenue,, 2013-2023, (US$ Mn)
  • 8.4 Europe
    • 8.4.1 Germany API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.4.2 U.K. API Market Revenue,, 2013-2023, (US$ Mn)
    • 8.4.3 Rest of Europe API Market Revenue,, 2013-2023, (US$ Mn)
  • 8.5 Rest of the World

Chapter 9 Recommendations

  • 9.1 Enhance manufacturing capacity through acquisitions in targeted geographies
  • 9.2 Achieve cost leadership in specific API molecules

Chapter 10 Company Profiles

  • 10.1 Allergan plc
  • 10.2 BASF SE
  • 10.3 Boehringer Ingelheim GmbH
  • 10.4 Cambrex Corporation
  • 10.5 Dr. Reddy's Laboratories
  • 10.6 Lonza Group
  • 10.7 Mylan N.V.
  • 10.8 Pfizer, Inc.
  • 10.9 Sandoz (Novartis AG)
  • 10.10 Teva Pharmaceutical Industries Ltd.
  • 10.11 WuXi AppTec
Back to Top